Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience’s Xafty by UCSD
SAN DIEGO, Sept. 17, 2024 /PRNewswire/ — Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an investigator-initiated trial to evaluate the efficacy of Xafty®, a niclosamide-based antiviral developed by its Korean headquar
Southwest Gas Holdings Declares Fourth Quarter 2024 Dividend
LAS VEGAS, Sept. 17, 2024 /PRNewswire/ — The Board of Directors for Southwest Gas Holdings, Inc. (“Southwest Gas”) (NYSE: SWX) has declared the following fourth quarter cash dividend: Common Stock Payable December 2, 2024 Of Record November 15, 2024 Dividend $0.62 per share The
ANDREW WHITWORTH AND LOS ANGELES RAMS TEAM UP WITH TOP LA CHEFS AND THE LOS ANGELES REGIONAL FOOD BANK TO RAISE FUNDS TO COMBAT FOOD INSECURITY
LOS ANGELES, Sept. 17, 2024 /PRNewswire/ — The 9th Annual Taste of the Rams event gathered approximately 600 guests to raise over $180,000 to bolster the work of the Los Angeles Regional Food Bank and its partners across LA County. The money raised will help support the mission of the Food Ban
Returning to Indonesia, The Pokémon Company Invites Fans to Enjoy the Exciting Adventure of Pikachu’s Indonesia Journey
JAKARTA, Indonesia , Sept. 17, 2024 /PRNewswire/ — Get ready to experience exciting adventures with beloved Pokémon characters at Pikachu’s Indonesia Journey, held on September 21 and 22, 2024, at Community Park Pantai Indah Kapuk 2 and PIK Avenue. The event will feature a variety of
Innovent Delivers Oral Presentations on Clinical Data of IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate) in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors at the 2024 ESMO Congress
SAN FRANCISCO and SUZHOU, China, Sept. 17, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascu
Innovent Announces Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Combined with Bevacizumab in Advanced Colorectal Cancer at the 2024 ESMO Congress
SAN FRANCISCO and SUZHOU, China, Sept. 17, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascul
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES PRICING OF SENIOR SECURED NOTES
KING OF PRUSSIA, Pa., Sept. 17, 2024 /PRNewswire/ — Universal Health Services, Inc. (NYSE: UHS) today announced the pricing of its previously announced public offering of senior secured notes. The Company priced the offering of $500 million aggregate principal amount of its 4.625% senior secu
Clorox Declares Regular Quarterly Dividend of $1.22 Per Share
OAKLAND, Calif., Sept. 17, 2024 /PRNewswire/ — The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.22 per share on the company’s common stock. The dividend is payable November 7, 2024, to shareholders of record as of the clos
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arhaus, Inc. – ARHS
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. T
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Franklin Resources, Inc. – BEN
NEW YORK, Sept. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, Inc. (“Franklin” or the “Company”) (NYSE: BEN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, e
